IL22 and neoplasm: At the same time, the decrease in MMP-2, MMP-9 SNAI1 and TWIST1 protein levels in IL-22 + LY294002 cells indicated that inhibition of the PI3K/AKT signaling pathway reduced MMP expression, attenuating tumor cell invasion and metastasis.